FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295088155> ?p ?o ?g. }

• W4295088155 endingPage "1308" @default.
• W4295088155 startingPage "1299" @default.
• W4295088155 abstract "Cytotoxic agents synergize with immune checkpoint inhibitors and improve outcomes for patients with several cancer types. Nonetheless, a parallel increase in the incidence of dose-limiting side effects, such as peripheral neuropathy, is often observed. Here, we investigated the role of the programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis in the modulation of paclitaxel-induced neuropathic pain. We found that human and mouse neural tissues, including the dorsal root ganglion (DRG), expressed basal levels of PD-1 and PD-L1. During the development of paclitaxel-induced neuropathy, an increase in PD-L1 expression was observed in macrophages from the DRG. This effect depended on Toll-like receptor 4 activation by paclitaxel. Furthermore, PD-L1 inhibited pain behavior triggered by paclitaxel or formalin in mice, suggesting that PD-1/PD-L1 signaling attenuates peripheral neuropathy development. Consistent with this, we observed that the combined use of anti-PD-L1 plus paclitaxel increased mechanical allodynia and chronic neuropathy development induced by single agents. This effect was associated with higher expression of inflammatory markers (Tnf, Il6, and Cx3cr1) in peripheral nervous tissue. Together, these results suggest that PD-1/PD-L1 inhibitors enhance paclitaxel-induced neuropathic pain by suppressing PD-1/PD-L1 antinociceptive signaling." @default.
• W4295088155 created "2022-09-10" @default.
• W4295088155 creator A5001247661 @default.
• W4295088155 creator A5001800556 @default.
• W4295088155 creator A5005247376 @default.
• W4295088155 creator A5006196353 @default.
• W4295088155 creator A5006994441 @default.
• W4295088155 creator A5017615120 @default.
• W4295088155 creator A5019431023 @default.
• W4295088155 creator A5022539185 @default.
• W4295088155 creator A5031901881 @default.
• W4295088155 creator A5043015303 @default.
• W4295088155 creator A5049092522 @default.
• W4295088155 creator A5050684767 @default.
• W4295088155 creator A5051765641 @default.
• W4295088155 creator A5055828816 @default.
• W4295088155 creator A5060460159 @default.
• W4295088155 creator A5060801593 @default.
• W4295088155 creator A5063296608 @default.
• W4295088155 creator A5071273328 @default.
• W4295088155 creator A5078982228 @default.
• W4295088155 creator A5083031217 @default.
• W4295088155 creator A5086104883 @default.
• W4295088155 creator A5091123504 @default.
• W4295088155 date "2022-09-09" @default.
• W4295088155 modified "2023-10-01" @default.
• W4295088155 title "PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling" @default.
• W4295088155 cites W1947705102 @default.
• W4295088155 cites W1989168171 @default.
• W4295088155 cites W2021065674 @default.
• W4295088155 cites W2039519643 @default.
• W4295088155 cites W2051636266 @default.
• W4295088155 cites W2052317102 @default.
• W4295088155 cites W2053242178 @default.
• W4295088155 cites W2130681302 @default.
• W4295088155 cites W2532352313 @default.
• W4295088155 cites W2547814918 @default.
• W4295088155 cites W2619512349 @default.
• W4295088155 cites W2775034956 @default.
• W4295088155 cites W2796582438 @default.
• W4295088155 cites W2802652754 @default.
• W4295088155 cites W2887408433 @default.
• W4295088155 cites W2897422388 @default.
• W4295088155 cites W2969593651 @default.
• W4295088155 cites W3045946240 @default.
• W4295088155 cites W3080211491 @default.
• W4295088155 cites W3087345764 @default.
• W4295088155 cites W3111075934 @default.
• W4295088155 cites W3129408413 @default.
• W4295088155 cites W4249390745 @default.
• W4295088155 cites W4249470680 @default.
• W4295088155 doi "https://doi.org/10.1158/2326-6066.cir-22-0003" @default.
• W4295088155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36083496" @default.
• W4295088155 hasPublicationYear "2022" @default.
• W4295088155 type Work @default.
• W4295088155 citedByCount "2" @default.
• W4295088155 countsByYear W42950881552023 @default.
• W4295088155 crossrefType "journal-article" @default.
• W4295088155 hasAuthorship W4295088155A5001247661 @default.
• W4295088155 hasAuthorship W4295088155A5001800556 @default.
• W4295088155 hasAuthorship W4295088155A5005247376 @default.
• W4295088155 hasAuthorship W4295088155A5006196353 @default.
• W4295088155 hasAuthorship W4295088155A5006994441 @default.
• W4295088155 hasAuthorship W4295088155A5017615120 @default.
• W4295088155 hasAuthorship W4295088155A5019431023 @default.
• W4295088155 hasAuthorship W4295088155A5022539185 @default.
• W4295088155 hasAuthorship W4295088155A5031901881 @default.
• W4295088155 hasAuthorship W4295088155A5043015303 @default.
• W4295088155 hasAuthorship W4295088155A5049092522 @default.
• W4295088155 hasAuthorship W4295088155A5050684767 @default.
• W4295088155 hasAuthorship W4295088155A5051765641 @default.
• W4295088155 hasAuthorship W4295088155A5055828816 @default.
• W4295088155 hasAuthorship W4295088155A5060460159 @default.
• W4295088155 hasAuthorship W4295088155A5060801593 @default.
• W4295088155 hasAuthorship W4295088155A5063296608 @default.
• W4295088155 hasAuthorship W4295088155A5071273328 @default.
• W4295088155 hasAuthorship W4295088155A5078982228 @default.
• W4295088155 hasAuthorship W4295088155A5083031217 @default.
• W4295088155 hasAuthorship W4295088155A5086104883 @default.
• W4295088155 hasAuthorship W4295088155A5091123504 @default.
• W4295088155 hasBestOaLocation W42950881552 @default.
• W4295088155 hasConcept C105702510 @default.
• W4295088155 hasConcept C121608353 @default.
• W4295088155 hasConcept C126322002 @default.
• W4295088155 hasConcept C134018914 @default.
• W4295088155 hasConcept C140530291 @default.
• W4295088155 hasConcept C15490471 @default.
• W4295088155 hasConcept C170493617 @default.
• W4295088155 hasConcept C2776281502 @default.
• W4295088155 hasConcept C2777107010 @default.
• W4295088155 hasConcept C2777292972 @default.
• W4295088155 hasConcept C2779245659 @default.
• W4295088155 hasConcept C2779901536 @default.
• W4295088155 hasConcept C555293320 @default.
• W4295088155 hasConcept C71924100 @default.
• W4295088155 hasConcept C98274493 @default.
• W4295088155 hasConceptScore W4295088155C105702510 @default.
• W4295088155 hasConceptScore W4295088155C121608353 @default.

• next